4.5 Review

Risk factors for acute kidney injury in COVID-19 patients: an updated systematic review and meta-analysis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Urology & Nephrology

UK prescribing practice of anticoagulants in patients with chronic kidney disease: a nephrology and haematology-based survey

Kathrine Parker et al.

Summary: A survey was conducted in the UK to understand anticoagulant prescribing practice in patients with chronic kidney disease (CKD). The survey revealed significant differences between nephrology doctors and haematology clinicians in anticoagulant management, as well as variation between different centres. The development of a best-practice guideline is warranted to provide support for clinicians in this field.

BMC NEPHROLOGY (2023)

Article Transplantation

Acute kidney injury in patients hospitalized with COVID-19 from the ISARIC WHO CCP-UK Study: a prospective, multicentre cohort study

Michael K. Sullivan et al.

Summary: This study investigated the occurrence of acute kidney injury (AKI) in hospitalized COVID-19 patients and found that AKI was common and associated with an increased risk of mortality. Chronic kidney disease, male sex, and Black race were identified as main risk factors for AKI and acute kidney replacement therapy.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2022)

Review Hematology

Incidence and Outcomes of Acute Kidney Injury in COVID-19: A Systematic Review

Rupesh Raina et al.

Summary: This comprehensive systematic review on AKI in COVID-19 patients found a high incidence of AKI and a relatively high proportion of patients requiring KRT in the COVID-19 population. The mortality rate was significantly higher among AKI patients compared to the overall COVID-19 patient population.

BLOOD PURIFICATION (2022)

Review Medicine, General & Internal

COVID-19 and Acute Kidney Injury: A Systematic Review

Tahereh Sabaghian et al.

Summary: Acute kidney injury (AKI) frequently complicates the course of COVID-19 hospitalizations and is associated with increased severity of illness, prolonged duration of hospitalization, and poor prognosis. Early detection of comorbidities and renal complications is essential to improve the outcomes of COVID-19 patients.

FRONTIERS IN MEDICINE (2022)

Article Medicine, General & Internal

Clinical characteristics and factors associated with acute kidney injury among patients hospitalized with coronavirus disease: an observational retrospective study

Edgar Dehesa-Lopez et al.

Summary: AKI is a common and serious complication among COVID-19 hospitalized patients, associated with higher mortality and longer hospital stay. Factors associated with AKI include chronic kidney disease, use of norepinephrine, diabetes mellitus, C-reactive protein level, and COVID-19 severity index based on chest tomography.

SAO PAULO MEDICAL JOURNAL (2022)

Article Medicine, General & Internal

Acute kidney injury in patients with COVID-19 in the intensive care unit: evaluation of risk factors and mortality in a national cohort

Eirik Aasen Aukland et al.

Summary: The prevalence and risk factors of acute kidney injury (AKI) in COVID-19 patients admitted to intensive care units (ICUs) in Norway were investigated. AKI was present in 32.0% of the patients at ICU admission and was related to acute circulatory failure at hospital admission. Age, acute circulatory failure at hospital admission, and AKI at ICU admission were associated with mortality.

BMJ OPEN (2022)

Review Cardiac & Cardiovascular Systems

Renin-Angiotensin System Inhibitors in Patients With COVID-19: A Meta-Analysis of Randomized Controlled Trials Led by the International Society of Hypertension

Sonali R. Gnanenthiran et al.

Summary: This meta-analysis suggests that the use of RASi in adults with COVID-19 does not increase all-cause mortality, slightly decreases the risk of acute myocardial infarction, but increases the risk of acute kidney injury.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2022)

Article Nutrition & Dietetics

Morbid obesity is associated with mortality and acute kidney injury in hospitalized patients with COVID-19

Fabiola Martin-del-Campo et al.

Summary: This study investigated the association of obesity with kidney outcomes and mortality in COVID-19 hospitalized patients, finding that morbid obesity was significantly associated with an increased risk of AKI, RRT, and mortality.

CLINICAL NUTRITION ESPEN (2021)

Article Hematology

Epidemiology and Outcomes of Acute Kidney Injury in COVID-19 Patients with Acute Respiratory Distress Syndrome: A Multicenter Retrospective Study

Feilong Wang et al.

Summary: This multicenter retrospective study found that nearly half of COVID-19 patients with ARDS experienced AKI during their hospital stay, and the coexistence of AKI significantly increased the mortality of these patients.

BLOOD PURIFICATION (2021)

Article Hematology

Acute Kidney Injury and Renal Replacement Therapy in Critically Ill COVID-19 Patients: Risk Factors and Outcomes: A Single-Center Experience in Brazil

Marisa Petrucelli Doher et al.

Summary: AKI is common among critically ill COVID-19 patients and is often associated with early IMV. One in six AKI patients required RRT, and one in three patients treated with RRT died in hospital. These findings provide important prognostic information for clinicians.

BLOOD PURIFICATION (2021)

Article Urology & Nephrology

Acute Kidney Injury in a National Cohort of Hospitalized US Veterans with COVID-19

Benjamin Bowe et al.

Summary: This study aimed to describe rates and outcomes of AKI in a national cohort of US veterans hospitalized with COVID-19. The results showed that AKI was common in these patients and associated with higher risk of health care resource utilization and death, with nearly half of patients not recovering to baseline by discharge. Substantial geographic variation and temporal decline in rates and severity of AKI were observed.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)

Editorial Material Medicine, General & Internal

Racial and Ethnic Health Disparities Related to COVID-19

Leo Lopez et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Article Urology & Nephrology

Risks of AKI and Major Adverse Clinical Outcomes in Patients with Severe Acute Respiratory Syndrome or Coronavirus Disease 2019

Jeremy Yuen-Chun Teoh et al.

Summary: The study found that patients with SARS had higher rates of acute kidney injury (AKI) and major adverse clinical outcomes compared to those with COVID-19. Diabetes mellitus and hypertension were significant factors associated with AKI in both SARS and COVID-19 patients. Patients with AKI in COVID-19 had lower rates of major adverse clinical outcomes compared to those with SARS, and renal function typically recovered within 30 days after an initial AKI event in both groups.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)

Article Biotechnology & Applied Microbiology

Acute Kidney Injury in Hospitalized Patients Infected with COVID-19 from Wuhan, China: A Retrospective Study

Yujie Dai et al.

Summary: This study investigated the risk factors of acute kidney injury (AKI) in patients infected with the novel coronavirus, and found that male sex, chronic kidney disease, hypertension, increased leukocytes, and diuretic use were independent risk factors for AKI in SARS-CoV-2 infected patients. Patients with AKI had higher mortality rates.

BIOMED RESEARCH INTERNATIONAL (2021)

Article Multidisciplinary Sciences

Mortality and evolution between community and hospital-acquired COVID-AKI

Jonathan S. Chavez-Iniguez et al.

Summary: Acute kidney injury (AKI) in COVID patients is linked to poor outcomes, with community-acquired AKI (CA-AKI) patients showing more comorbidities compared to hospital-acquired AKI (HA-AKI) patients. Despite these differences, the mortality rates are similar between the two groups.

PLOS ONE (2021)

Article Multidisciplinary Sciences

Risk factors, predictions, and progression of acute kidney injury in hospitalized COVID-19 patients: An observational retrospective cohort study

Maryam N. Naser et al.

Summary: Studies have shown that the occurrence of acute kidney injury (AKI) in hospitalized COVID-19 patients is high and associated with AKI staging. In addition to age, diabetes and hypertension are major risk factors for AKI development, while multiple comorbidities significantly increase the risk.

PLOS ONE (2021)

Article Multidisciplinary Sciences

Acute kidney injury in patients with severe COVID-19 in Mexico

Gustavo A. Casas-Aparicio et al.

Summary: Acute kidney injury is common in severe COVID-19 patients, with older age, obesity, and the need for mechanical ventilation on admission being risk factors for AKI. Obesity, requirement of vasoactive drugs on admission, and AKI were found to be risk factors for mortality. Mortality rates were higher in patients with AKI stages 2-3, and the furosemide stress test showed acceptable predictive capacity for identifying progression to AKI stage 3.

PLOS ONE (2021)

Article Urology & Nephrology

COVID-19-related acute kidney injury; incidence, risk factors and outcomes in a large UK cohort

Paul D. Jewell et al.

Summary: AKI is common among COVID-19 patients in a large UK tertiary center, with 39% of inpatients experiencing AKI. Pre-existing renal impairment and inpatient diuretic use are associated with a higher risk of AKI. AKI is a strong predictor of 30-day mortality, even at stage 1, and one third of AKI3 survivors exhibit newly established renal impairment at 3-6 months.

BMC NEPHROLOGY (2021)

Letter Anesthesiology

Acute kidney injury in severe SARS-CoV-2 infection: An experience report in Eastern France

Guillaume Louis et al.

ANAESTHESIA CRITICAL CARE & PAIN MEDICINE (2021)

Article Urology & Nephrology

Acute kidney injury in 3182 patients admitted with COVID-19: a single-center, retrospective, case-control study

Fabio L. Procaccini et al.

Summary: AKI is common in COVID-19 patients and often caused by prerenal and sepsis. Pre-existing hypertension, chronic kidney disease, and respiratory distress are risk factors for AKI. Low arterial pressure at admission increases the risk for Stage 3 AKI. Some AKI patients do not recover baseline kidney function and AKI significantly increases mortality risk.

CLINICAL KIDNEY JOURNAL (2021)

Article Urology & Nephrology

Decreasing Incidence of Acute Kidney Injury in Patients with COVID-19 Critical Illness in New York City

David M. Charytan et al.

Summary: Acute kidney injury (AKI) frequently complicates COVID-19 and is associated with high mortality, especially when renal replacement therapy (RRT) is required. However, AKI incidence appears to be decreasing over time and kidney function often recovers in most survivors.

KIDNEY INTERNATIONAL REPORTS (2021)

Article Endocrinology & Metabolism

Overweight and Obesity Are Associated With Acute Kidney Injury and Acute Respiratory Distress Syndrome, but Not With Increased Mortality in Hospitalized COVID-19 Patients: A Retrospective Cohort Study

Jamie van Son et al.

Summary: Overweight and obesity were associated with acute respiratory distress syndrome and acute kidney injury in hospitalized COVID-19 patients, but not with in-hospital mortality or length of hospital stay.

FRONTIERS IN ENDOCRINOLOGY (2021)

Article Medicine, General & Internal

Acute Kidney Disease and Mortality in Acute Kidney Injury Patients with COVID-19

Filipe Marques et al.

Summary: The study retrospectively analyzed COVID-19 patients with AKI admitted at Centro Hospitalar Universitario Lisboa Norte between March and August 2020. It found that factors such as hypertension, CKD, lower hemoglobin and CRP levels, as well as nephrotoxin exposure were independent risk factors for the development of AKD. Older age, higher serum ferritin levels at admission, and development of AKD were independent predictors of in-hospital mortality in COVID-19-AKI patients.

JOURNAL OF CLINICAL MEDICINE (2021)

Review Medicine, General & Internal

Risk Factors for Acute Kidney Injury in Adult Patients With COVID-19: A Systematic Review and Meta-Analysis

Xiaoyue Cai et al.

Summary: The study revealed that male sex, age, smoking, obesity, hypertension, diabetes, pneumopathy, cardiovascular disease, cancer, chronic kidney disease (CKD), mechanical ventilation, and the use of vasopressors were significant risk factors for acute kidney injury (AKI) in adult patients with COVID-19.

FRONTIERS IN MEDICINE (2021)

Article Urology & Nephrology

Acute kidney injury in COVID-19: multicentre prospective analysis of registry data

Yize Wan et al.

Summary: Analysis of AKI data in COVID-19 patients reveals that AKI significantly increases mortality, with severity of AKI positively associated with mortality. Persistent AKI is linked to higher mortality rates.

CLINICAL KIDNEY JOURNAL (2021)

Review Medicine, General & Internal

Association Between Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in Patients With COVID-19 A Systematic Review and Meta-analysis

Ranu Baral et al.

Summary: A systematic review and meta-analysis found that receipt of ACEIs or ARBs was not associated with a higher risk of multivariable-adjusted mortality and severe adverse events among patients with COVID-19, especially for those with hypertension.

JAMA NETWORK OPEN (2021)

Article Virology

Critical roles of cytokine storm and secondary bacterial infection in acute kidney injury development in COVID-19: A multi-center retrospective cohort study

Xia-Qing Li et al.

Summary: Acute kidney injury (AKI) is common in COVID-19 patients and is more prevalent in severe cases. Factors such as cytokine storm, ARDS, and kidney injury at admission play a significant role in the development of AKI. Long-term mechanical ventilation, cytokine storms, and secondary bacterial infections contribute to AKI-related mortality in COVID-19 patients.

JOURNAL OF MEDICAL VIROLOGY (2021)

Article Physiology

The Risk Factors and Clinical Outcomes Associated with Acute Kidney Injury in Patients with COVID-19: Data from a Large Cohort in Iran

Hormat Rahimzadeh et al.

Summary: The study in Iran on AKI in COVID-19 patients identified male sex, history of CKD, hypertension, disease severity, and high serum urea as independent risk factors for AKI development. Higher stages of AKI were associated with increased mortality and in-hospital complications. Lack of AKI recovery at discharge is common in COVID-19 patients, highlighting the need for more precise care and monitoring.

KIDNEY & BLOOD PRESSURE RESEARCH (2021)

Article Urology & Nephrology

Community- versus hospital-acquired acute kidney injury in hospitalised COVID-19 patients

Jack S. Bell et al.

Summary: AKI is a common complication in COVID-19 patients, with both community- and hospital-acquired AKI sharing similar risk factors related to pre-renal injury. Hospital-acquired AKI, but not community-acquired AKI, is significantly associated with mortality, highlighting the importance of monitoring kidney function in hospitalized COVID-19 patients.

BMC NEPHROLOGY (2021)

Article Critical Care Medicine

Acute kidney injury in SARS-CoV2-related pneumonia ICU patients: a retrospective multicenter study

Guillaume Geri et al.

Summary: The study found that AKI was frequent in severe COVID-19 patients, driven mainly by preexisting chronic kidney disease and life-sustaining therapies. However, the adjusted relationship between AKI and day 28 mortality remains unclear.

ANNALS OF INTENSIVE CARE (2021)

Article Medicine, General & Internal

Atrial Fibrillation and Clinical Outcomes in a Cohort of Hospitalized Patients with Sars-Cov-2 Infection and Chronic Kidney Disease

Simonetta Genovesi et al.

Summary: This study found that chronic kidney disease has an impact on in-hospital mortality and incident atrial fibrillation in patients with SARS-CoV-2 infection. The occurrence of acute kidney injury is also an important factor.

JOURNAL OF CLINICAL MEDICINE (2021)

Review Medicine, General & Internal

Global REnal Involvement of CORonavirus Disease 2019 (RECORD): A Systematic Review and Meta-Analysis of Incidence, Risk Factors, and Clinical Outcomes

Kam Wa Chan et al.

Summary: This study aimed to assess the association between AKI, mortality, underlying non-communicable diseases, and clinical risk factors among COVID-19 patients. Patients with underlying comorbidities such as chronic kidney disease, hypertension, diabetes, and history of tumors had increased incidence rates of AKI. Patients who developed AKI during hospitalization had significantly higher odds of death or being critical.

FRONTIERS IN MEDICINE (2021)

Article Urology & Nephrology

Risk Factors for Development of Acute Kidney Injury in COVID-19 Patients: A Retrospective Observational Cohort Study

Yong Pey See et al.

Summary: Severe COVID-19 is independently associated with an increased risk of AKI, with age, vancomycin exposure, and NSAIDs use also playing a role in the development of AKI in COVID-19 patients.

NEPHRON (2021)

Article Medical Informatics

Renin-angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysis

Daniel R. Morales et al.

Summary: The study found no significant association between the use of ACEIs or ARBs and COVID-19 diagnosis and hospital admission in patients with hypertension, suggesting that users should not stop or change their treatment to reduce the risk of COVID-19.

LANCET DIGITAL HEALTH (2021)

Article Medicine, General & Internal

Acute kidney injury in patients with COVID-19: a retrospective cohort study from Switzerland

Matthias Diebold et al.

Summary: Data on AKI in European COVID-19 patients are limited. A study in a Swiss tertiary hospital found AKI to be common in hospitalized COVID-19 patients, especially those with severe illness. Risk factors for AKI included age, history of chronic kidney disease, C-reactive protein levels, and creatinine kinase.

SWISS MEDICAL WEEKLY (2021)

Review Public, Environmental & Occupational Health

Association Between Ethnicity and Severe COVID-19 Disease: a Systematic Review and Meta-analysis

Antony Raharja et al.

Summary: This study found that compared to White ethnicity, Black and Asian populations had similar overall mortality rates, while Hispanic ethnicity had lower overall mortality rates. After adjusting for age, sex, and comorbidities, the elevated risks for Black and Asian populations became non-significant. There was a trend towards greater disparities in COVID-19 outcomes for ethnic minorities in the UK.

JOURNAL OF RACIAL AND ETHNIC HEALTH DISPARITIES (2021)

Article Urology & Nephrology

Acute kidney injury in patients hospitalized with COVID-19

Jamie S. Hirsch et al.

KIDNEY INTERNATIONAL (2020)

Article Cardiac & Cardiovascular Systems

Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)

Tao Guo et al.

JAMA CARDIOLOGY (2020)

Review Medicine, General & Internal

Renal complications in COVID-19: a systematic review and meta-analysis

Setor K. Kunutsor et al.

ANNALS OF MEDICINE (2020)

Article Medicine, General & Internal

Incidence of acute kidney injury and its association with mortality in patients with COVID-19: a meta-analysis

Panupong Hansrivijit et al.

JOURNAL OF INVESTIGATIVE MEDICINE (2020)

Article Urology & Nephrology

The Incidence, Risk Factors, and Prognosis of Acute Kidney Injury in Adult Patients with Coronavirus Disease 2019

Yichun Cheng et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)

Article Multidisciplinary Sciences

Clinical characteristics of 82 cases of death from COVID-19

Bicheng Zhang et al.

PLOS ONE (2020)

Article Clinical Neurology

Cerebrovascular Complications of COVID-19

Jeffrey M. Katz et al.

STROKE (2020)

Article Medicine, General & Internal

Association between Chronic Kidney Disease or Acute Kidney Injury and Clinical Outcomes in COVID-19 Patients

Seok Hui Kang et al.

JOURNAL OF KOREAN MEDICAL SCIENCE (2020)

Article Multidisciplinary Sciences

Characteristics and outcomes of hospitalised patients with acute kidney injury and COVID-19

Patrick Hamilton et al.

PLOS ONE (2020)

Article Immunology

Considering how biological sex impacts immune responses and COVID-19 outcomes

Eileen P. Scully et al.

NATURE REVIEWS IMMUNOLOGY (2020)

Review Urology & Nephrology

Acute kidney injury and kidney replacement therapy in COVID-19: a systematic review and meta-analysis

Edouard L. Fu et al.

CLINICAL KIDNEY JOURNAL (2020)

Article Medicine, General & Internal

Risk factors and prognosis for COVID-19-induced acute kidney injury: a meta-analysis

Lirong Lin et al.

BMJ OPEN (2020)

Review Ethics

Implicit bias in healthcare professionals: a systematic review

Chloe FitzGerald et al.

BMC MEDICAL ETHICS (2017)

Article Urology & Nephrology

Acute Respiratory Distress Syndrome and Risk of AKI among Critically Ill Patients

Michael Darmon et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)

Article Critical Care Medicine

Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury

Ravindra L. Mehta et al.

CRITICAL CARE (2007)

Article Medicine, General & Internal

Measuring inconsistency in meta-analyses

JPT Higgins et al.

BMJ-BRITISH MEDICAL JOURNAL (2003)